Gene and Cell
Therapy Society


The aims of the Australasian Gene and Cell Therapy Society (AGCTS)


To facilitate the growth and development of the field of gene and cell therapy in Australasia


To represent the goals of the Australasian gene and cell therapy community before government and the public


To disseminate information regarding the safe and ethical use of gene and cell therapy methodologies


To act as a resource of gene and cell therapy protocols, reagents and scientific exchanges


Dear AGCTS Members,

While we are meeting on-line rather than in person at this AGM, it is great to see you, and I’m grateful that you have made the time to join us. Our society exists to support the needs of its members in their endeavours to advance gene and cell therapies, so your involvement and your feedback is vital. For that, I thank you.
I also wish to express my thanks for once again having the opportunity to serve as your President for the 2019-2021 cycle. It is always an honour and privilege to have your support. But the real credit lies with our Executive Committee, for all that they do. Their dedication to AGCTS doesn’t receive enough recognition, so I ask that in your own way please make time to thank Jim Vadolas (Vice President), Ann Simpson (Treasurer), Samantha Ginn (Secretary), May Aung-Htut, Livia Carvalho, Sharon Cunningham, Cindy Kok, and Leszek Lisowski, and our ex officio member, Steve Wilton for their continued dedication to The Society. We are deeply grateful to them.

Scroll to Top